![Rajkumar Kannan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rajkumar Kannan
Directeur/Membre du Conseil chez
AMRYT PHARMA PLC
Profil
Rajkumar Kannan is currently Chief Executive Officer & Director at Alveus Therapeutics, Inc. since 2025, Chief Executive Officer & Director at Alveus Therapeutics ApS, and Non-Executive Director at Amryt Pharma PLC since 2021.
Former roles include Chief Executive Officer & Director at Aerie Pharmaceuticals, Inc. from 2021 to 2022, President, Chief Executive Officer & Director at Chiasma, Inc. in 2021, Chief Executive Officer & Director at I-MAB Biopharma Co., Ltd., Chief Executive Officer & Director at NovaBridge Biosciences from 2023 to 2024, Non-Executive Director at Amryt Pharma Holdings Ltd., Global Head-Neurology & Immunology at Merck KGaA from 1995 to 2004, Head-Cardiovascular Franchise Global Marketing at Boehringer Ingelheim Corp.
from 2004 to 2014, and Chief Commercial Officer at Kiniksa Pharmaceuticals Ltd. from 2018 to 2019.
Education includes an MBA from East Carolina University and an undergraduate degree from the University of Madras.
Postes actifs de Rajkumar Kannan
| Sociétés | Poste | Début |
|---|---|---|
| AMRYT PHARMA PLC | Directeur/Membre du Conseil | 05/08/2021 |
Anciens postes connus de Rajkumar Kannan
| Sociétés | Poste | Fin |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Directeur Général | 15/07/2024 |
| AERIE PHARMACEUTICALS, INC. | Directeur Général | 21/11/2022 |
| CHIASMA, INC. | Directeur Général | 05/08/2021 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Corporate Officer/Principal | 01/06/2019 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Sales & Marketing | 01/06/2014 |
Formation de Rajkumar Kannan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
East Carolina University
 East Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Madras
 University of Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Choisissez Zonebourse 
